Why iSpecimen Stock Whipsawed After Its 1-for-40 Reverse Split
iSpecimen Inc. shares fell 8.2% to $4.80 Friday after volatile trading, following a 1-for-40 reverse stock split aimed at meeting Nasdaq’s minimum bid price. The split reduced outstanding shares from 52.6 million to about 1.3 million. Nasdaq has given the company until May 18 to regain compliance. The annual meeting is set for May 8 after previous adjournments due to lack of quorum.